Esther Alonso Gil

Esther Alonso Gil currently serves as Associate Director in Explo R&D Regulatory Affairs at Eli Lilly and Company since August 2025. Previously, Esther was the Global Regulatory Affairs Specialist for Indero (formerly Innovaderm) from May 2024 to August 2025, overseeing regulatory strategy for clinical trials across multiple countries. Esther's earlier experience includes roles as a Senior Regulatory Affairs Specialist at ICON plc, where preparation and submission of regulatory documentation in Spain were key responsibilities, and as a Regulatory & Start-up Specialist at IQVIA, managing regulatory documentation and submissions for clinical trial initiation. Esther began professional career as a Pharmacist at Farmacia Concepcion Clavero y Atila Ochoa, focusing on medication dispensing and patient advice. Educational background includes a Pharmacy degree from Universidad Complutense de Madrid and upcoming master's degrees in Big Data and Business Intelligence, as well as Project Management from Universidad Isabel I.